Wednesday, March 30, 2016

BRIEF-Epigenomics enters agreement with Biochain on lung cancer test for China

* Enters strategic license and development agreement with Biochain on novel, blood-based lung cancer test for China











Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)